Immunosuppressive therapy for progressive idiopathic membranous nephropathy: a cost-effectiveness analysis in China

BACKGROUND: This study aims to evaluate the cost-effectiveness of immunosuppressive therapy for patients with progressive idiopathic membranous nephropathy (IMN) from the Chinese healthcare system perspective. METHODS: To estimate the cost-effectiveness of four regimens namely cyclophosphamide, cycl...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Wanyi, Zhang, Zhiqi, Li, Dandan, Dai, Wendi, Pan, Chen, Guo, Mingxing, Zhao, Ying, Cui, Xiangli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091593/
https://www.ncbi.nlm.nih.gov/pubmed/37046255
http://dx.doi.org/10.1186/s12913-023-09365-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091593/
https://www.ncbi.nlm.nih.gov/pubmed/37046255
http://dx.doi.org/10.1186/s12913-023-09365-z

Ejemplares similares